CMAC Industry Director, University of Strathclyde
Massimo Bresciani is the Industry Director at the Advanced Crystallisation and Medicines Manufacturing Research Centre based at Strathclyde (CMAC) and is actively supporting the group of Professors of Practice at Strathclyde University on various strategic initiatives.
Massimo holds an MBA and has a wealth of experience from over 25 years spent in the pharmaceutical and innovation sector in senior industrial R&D and manufacturing roles and at the interface between research and commercial application of innovative solutions. Massimo’s consolidated multidisciplinary expertise in pharmaceutical development and drug delivery technologies applies to both generic drugs and NCEs from lead optimisation throughout all the preclinical and clinical phase, and includes extensive experience in the early phases regulatory landscape.
Massimo is active internationally in innovation and alliance management, the creation of coopetitive partnership and associated strategy, collaborative alliances and pre-competitive consortia. He is a decision maker based on facts and both short and long-term vision.
A former board member of the Geriatric Medicine Society, he remains active in the field of patient centric and life science initiatives.